Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023

Fergus Hamilton, Elizabeth Darley, Alasdair MacGowan
doi: https://doi.org/10.1101/2024.03.04.24303729

Article Information

doi 
https://doi.org/10.1101/2024.03.04.24303729
History 
  • March 5, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Fergus Hamilton1,2,*,
  2. Elizabeth Darley2 and
  3. Alasdair MacGowan2
  1. 1MRC Integrative Epidemiology Unit, University of Bristol
  2. 2Infection Science, North Bristol NHS Trust
  1. ↵*Corresponding author; email: fergus.hamilton{at}bristol.ac.uk
Back to top
Posted March 05, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023
Fergus Hamilton, Elizabeth Darley, Alasdair MacGowan
medRxiv 2024.03.04.24303729; doi: https://doi.org/10.1101/2024.03.04.24303729
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area